News from AHA 2024: BROOKLYN, obicetrapib, CETPi in HeFH

Media formats available:

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Establishing Best Practices for Collaborative Care for Patients with ASCVD Between Academic and Rural Providers
Establishing Best Practices for Collaborative Care for Patients with ASCVD Between Academic and Rural Providers
CME/CE
Establishing Best Practices for Collaborative Care for Patients with ASCVD Between Academic and Rural Providers
1.00 credit
- Ty J. Gluckman, MD, MHA, FACC, FAHA, FASPC
- Rishi Wadhera, MD, MPP, Mphil
1.00 credit
Advances in Care for ATTR-CM: Current and Emerging Strategies
Advances in Care for ATTR-CM: Current and Emerging Strategies
Heart Matters
Advances in Care for ATTR-CM: Current and Emerging Strategies
- Gautam Nayak, MD
Complexities in ATTR-CM Care: Key Considerations for Accurate Diagnosis
Complexities in ATTR-CM Care: Key Considerations for Accurate Diagnosis
Heart Matters
Complexities in ATTR-CM Care: Key Considerations for Accurate Diagnosis
- Gautam Nayak, MD
Understanding the Pathophysiology Behind ATTR-CM
Understanding the Pathophysiology Behind ATTR-CM
Heart Matters
Understanding the Pathophysiology Behind ATTR-CM
- Frederick Ruberg, MD

Obicetrapib lowers LDL-c on top of other lipid-lowering therapies in HeFH